Skip to main content
User picture
Phone: +420 585632200
Groups: DOCTORAL STUDENT, EXSTAFF, IMTM, LEM

Doctoral training

Multimodal imaging for in vivo testing of selected biomolecules

Invasive microbial infections are one of the main causes of morbidity and mortality in immunocompromised patients. Early and accurate diagnosis is the key factor of a successful treatment. Siderophores are low-molecular-mass molecules that are produced by almost all microorganisms and used for iron acquisition. Iron is an essential nutrient for many microorganisms and its need is increased during active infection. Replacing iron with suitable radionuclide, such as gallium-68, could enable the detection of microbial infections by means of molecular imaging.

Specialization: Pediatrics
Status: Ongoing from 2020.

About me

Researcher and Ph.D. candidate at the Institute of Molecular and Translational Medicine in the field of radiopharmacy and molecular imaging. My research is focused on radiolabeled compounds for microPET/SPECT/MRI/CT imaging, in vitro analysis of radiolabeled compounds (radio-HPLC, radio-iTLC, gamma counter analysis) and in vivo/ex vivo biodistribution studies. The aim of my research is to develop a novel probe for imaging of pulmonary bacterial infections.

Orcid: https://orcid.org/0000-0001-6681-0100

Journals

TAS, H., M. SCHAFER, U. SHUJA-UDDIN, U. BAUDER-WUST, L. KOVACS DOS SANTOS, L. BARNITZKY, F. ODEN, M. PLATZK, T. KONIG, P. RUTHER, E. POOK, K. DVOŘÁKOVÁ BENDOVÁ, Z. NOVÝ, M. PETŘÍK, U. HAGEMANN, M. BENESOVA-SCHAFER
Investigation of Radiolabeled KISS1R Ligands as Promising Tools for Diagnosis and Treatment of Triple-Negative Breast Cancer. Molecular Pharmaceutics. 2026, ISSN: 1543-8384, PMID: 41774810,  PDF.
New insights into radiolabelled siderophores for molecular imaging of bacterial infections. Npj Imaging. 2025, 3(1), 63, ISSN: 2948-197X, PMID: 41299021,
GARIGLIO, G., T. HASENOHRL, K. DVOŘÁKOVÁ BENDOVÁ, Z. NOVÝ, C. RANGGER, K. KUMMER, B. SMITH, B. MATUSZCZAK, M. PETŘÍK, C. DECRISTOFORO
Novel dimeric dual-modality FAP-targeted agents with favorable tumor retention for image-guided surgery: a preclinical study. European journal of nuclear medicine and molecular imaging. 2026, 53(4), 2578-2591, ISSN: 1619-7070, PMID: 41258458,  PDF.